Skip to main content
Top

International Journal of Hematology

Issue 5/2014

Including PIH Articles on Noncoding RNA in hematopoietic system

Content (22 Articles)

Images in Hematology

Pan-ocular hemorrhage in thrombotic thrombocytopenic purpura

Aniruddha Agarwal, Jagat Ram

Progress in Hematology

Long noncoding RNAs during normal and malignant hematopoiesis

Juan R. Alvarez-Dominguez, Wenqian Hu, Austin A. Gromatzky, Harvey F. Lodish

Progress in Hematology

Small RNA as a regulator of hematopoietic development, immune response in infection and tumorigenesis

Kazuki Okuyama, Jun Ogata, Natsuko Yamakawa, Bidisha Chanda, Ai Kotani

Original Article

Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice

Yusuke Sasaki, Mariko Noguchi-Sasaki, Yukari Matsuo-Tezuka, Yuki Matsumoto-Omori, Mitsue Kurasawa, Keigo Yorozu, Yasushi Shimonaka

Original Article

Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia

Koji Kawaguchi, Kousaku Matsubara, Toshiro Takafuta, Isaku Shinzato, Yasuhiro Tanaka, Aya Iwata, Hiroyuki Nigami, Yasuhito Takeuchi, Takashi Fukaya

Original Article

Laboratory tests for coagulation system monitoring in a patient with β-thalassemia

Elena A. Seregina, Olga F. Nikulina, Nina V. Tsvetaeva, Maya N. Rodionova, Irina V. Gribkova, Elena B. Orel, Anastasiya P. Zapariy, Anatoliy V. Erasov, Anna N. Balandina, Natalya M. Ananyeva, Fazoil I. Ataullakhanov

Original Article

Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia

Yoshihito Morimoto, Nao Yoshida, Nozomu Kawashima, Kimikazu Matsumoto, Koji Kato

Original Article

Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia

Limin Liu, Yanming Zhang, Zhengming Jin, Xingxia Zhang, Guangsheng Zhao, Yejun Si, Guoqiang Lin, Aidi Ma, Yingxin Sun, Li Wang, Depei Wu

Original Article

ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases

Michinori Aoe, Akira Shimada, Michiko Muraoka, Kana Washio, Yoshimi Nakamura, Takahide Takahashi, Masahide Imada, Toshiyuki Watanabe, Ken Okada, Ritsuo Nishiuchi, Takako Miyamura, Kosuke Chayama, Misako Shibakura, Megumi Oda, Tsuneo Morishima

Original Article

Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study

Michele Baccarani, Brian J. Druker, Susan Branford, Dong-Wook Kim, Fabrizio Pane, Lidia Mongay, Manisha Mone, Christine-Elke Ortmann, Hagop M. Kantarjian, Jerald P. Radich, Timothy P. Hughes, Jorge E. Cortes, François Guilhot

Original Article

JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan

Yoko Edahiro, Soji Morishita, Kochi Takahashi, Yumi Hironaka, Yuriko Yahata, Yoshitaka Sunami, Shuichi Shirane, Miyuki Tsutsui, Masaaki Noguchi, Michiaki Koike, Kiyotoshi Imai, Keita Kirito, Naohiro Noda, Yuji Sekiguchi, Satoshi Tsuneda, Akimichi Ohsaka, Marito Araki, Norio Komatsu

Original Article

Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes

Yundeok Kim, In-Ho Kim, Hyeong Joon Kim, Silvia Park, Kyoo-Hyung Lee, Soo Jeong Kim, Jung-Hee Lee, Dae-Young Kim, Sung-Soo Yoon, Yeo-Keoung Kim, Jun Ho Jang, Seon Yang Park, Jae-Sook Ahn, Chul Won Cheong, Je-Hwan Lee, June-Won Cheong

Original Article

Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: a 10-year experience of the Okayama BMT Group

Nobuharu Fujii, Koichi Nakase, Shoji Asakura, Keitaro Matsuo, Yuichiro Nawa, Kazutaka Sunami, Hisakazu Nishimori, Ken-ichi Matsuoka, Eisei Kondo, Yoshinobu Maeda, Katsuji Shinagawa, Masamichi Hara, Mitsune Tanimoto

Original Article

A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning

Shinsuke Takagi, Hideki Araoka, Naoyuki Uchida, Yumiko Uchida, Daisuke Kaji, Hikari Ota, Aya Nishida, Kazuya Ishiwata, Masanori Tsuji, Hisashi Yamamoto, Tadaaki Ito, Naofumi Matsuno, Go Yamamoto, Yuki Asano-Mori, Masahiro Hayashi, Koji Izutsu, Kazuhiro Masuoka, Atsushi Wake, Shigeyoshi Makino, Akiko Yoneyama, Shuichi Taniguchi

Case Report

Complete remission of Sweet’s syndrome after azacytidine treatment for concomitant myelodysplastic syndrome

Sara Martinelli, Gian Matteo Rigolin, Genesio Leo, Roberta Gafà, Enrico Lista, Francesca Cibien, Olga Sofritti, Giulia Daghia, Francesco Cavazzini, Antonio Cuneo

Case Report

Spontaneous regression of essential thrombocythemia with MPL mutation on menopause

Maki Otsuka, Shuichi Hanada, Kayo Arita, Haruhiko Ohashi

Case Report

Infectious mononucleosis accompanied by clonal proliferation of EBV-infected cells and infection of CD8-positive cells

Ayako Arai, Takeshi Yamaguchi, Honami Komatsu, Ken-Ichi Imadome, Morito Kurata, Kaoru Nagata, Osamu Miura

Erratum

Erratum to: A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning

Shinsuke Takagi, Hideki Araoka, Naoyuki Uchida, Yumiko Uchida, Daisuke Kaji, Hikari Ota, Aya Nishida, Kazuya Ishiwata, Masanori Tsuji, Hisashi Yamamoto, Tadaaki Ito, Naofumi Matsuno, Go Yamamoto, Yuki Asano-Mori, Masahiro Hayashi, Koji Izutsu, Kazuhiro Masuoka, Atsushi Wake, Shigeyoshi Makino, Akiko Yoneyama, Shuichi Taniguchi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine